Robotics

Vicarious Surgical Announces Changes to Board of Directors

Tech-Focused Venture Capitalists Dror Berman and Samir Kaul to Resign

Beverly Huss Elected to Board of Directors

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the resignation of technology-focused venture capitalists Dror Berman and Samir Kaul from the Vicarious Surgical Board of Directors effective October 18, 2022. The Company also announced the appointment of Beverly Huss to the Vicarious Surgical Board of Directors, effective as of the same day. Ms. Huss will serve as a member of the Board’s Audit Committee.

“On behalf of the Board, I would like to thank Samir and Dror for their meaningful contributions and dedication to Vicarious Surgical over the past years; both have been instrumental in Vicarious’ evolution from tech start-up into the public, surgical robotic company that it is today,” said David Styka, Chairman of the Vicarious Surgical Board. “We are excited to welcome Beverly to the Vicarious team, where she will undoubtedly be a tremendous resource given her decades of broad experience in the medical device field and reputation as a visionary leader earned through successful pursuits across research and development, manufacturing, marketing and commercialization. Beverly’s involvement will be invaluable in advancing the Vicarious strategy.”

“I am honored to join the Vicarious Surgical Board at this exciting phase for the Company,” said Ms. Huss. “The Vicarious system possesses a number of differentiating factors that I believe hold the potential to transform the standard in surgical robotics. I look forward to working closely with my fellow board members and the Vicarious leadership team in their pursuit to bring these advancements to patients in need.”

Ms. Huss co-founded and previously served as Chief Executive Officer of Pagonia Medical, a development stage company in the tissue preservation market, where she led the incorporation efforts and seed capital financing. Prior to this, Ms. Huss served over several years as Chief Executive Officer of Qool Therapeutics, Inc., a therapeutic hypothermia and medical device company, and as Chief Executive Officer of Vibrynt, Inc., a start-up medical device company dedicated to creating minimally invasive therapies for patients suffering from morbid obesity. From 1986 to 2005, Ms. Huss served in various general management roles of increasing responsibility within the research and development, regulatory affairs, marketing and sales departments of Guidant Corporation, a market leading medical device company focused on treatment of cardiac rhythm management, cardiovascular and peripheral vascular disease through minimally invasive therapies, until its acquisition by Boston Scientific Corporation.

Ms. Huss is a veteran board member with nearly two decades of board experience and presently resides on the Boards of Accuray Incorporated, Ancora Heart, Inc., Iridex Corporation and Madorra, Inc. She received a Bachelor of Science in metallurgical engineering from the University of Illinois Urbana-Champaign and a Master’s degree in technology management from Pepperdine University.

Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!

Related posts

ST Robotics Launches New Delta Industrial Robot

PR Newswire

UNFI and Symbotic enter into a commercial agreement

Business Wire

Soft Robotics Launches SoftAI™ to adopt robots in Food Processing

PR Newswire